Skip to main content
Home
About
Who We Are
History
Governance
Board of Members
Board of Directors
Executive Management
Senior Management
Principal Investigators
Our Capacity
Partners
Collaborators
Sponsors
Careers
Tenders
Download Expression of Interest
Policies
Research
Research Themes
Studies
Ongoing Studies
Completed Studies
Laboratory
Pharmacy
Clinical Research Sites
Data Management
Regulatory
Publications
Capacity Building
Training
Projects
Community Engagement
Community Engagement Activities
Community Advisory Boards
Media
News
Newsletters
Press Releases
Annual Reports
Videos
Donate
Menu
Search
Studies
Download PDF
Status:Ongoing
Find Out More
HVTN 703/HPTN 081 (AMP Study): A phase 2b study to evaluate the efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection in women in Sub- Saharan Africa.
Status:Ongoing
Find Out More
HVTN805/HPTN093: Antiretroviral analytical treatment interruption (ATI) to assess immunologic and virologic responses in participants who initiated ART in early HIV infection after having received VRC01 or placebo in HVTN 703/HPTN 081.
Status:Ongoing
Find Out More
IMPAACT 2005
Status:Ongoing
Find Out More
IMPAACT 2017 - Phase I/II Study of the Safety, Acceptability, Tolerability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Long-Acting Injectable Rilpivirine in Virologically Suppressed HIV-Infected Children and Adolescents
Status:Ongoing
Find Out More
IMPAACT 2019 – Phase I/II Study of the Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less than 12 Years of Age
Status:Ongoing
Find Out More
Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern: CoVPN 3008
Status:Ongoing
Find Out More
Open-Label, Single-Arm, Phase 3B Study of the Incidence of Severe COVID-19 and Adverse Events Following AZD1222 COVID-19 Vaccination in Botswana Against SARS-CoV-2
Status:Ongoing
Find Out More
P1093 - Phase I/II, Multi-Centre, Open-Label Pharmacokinetic, Safety, Tolerability and Antiviral Activity of Dolutegravir, a Novel Integrase Inhibitor, in Combination Regimens in HIV-1 Infected Infants, Children and Adolescents
Status:Ongoing
Find Out More
PHOENIx (A5300B): Protecting Households on Exposure to Newly Diagnosed Index Multidrug Resistant TB patients
Status:Ongoing
Find Out More
REPRIEVE (A5332): A randomized trial to prevent vascular events (such as stroke and heart attack) in people living with HIV.
Status:Completed
Find Out More
A Randomized Study of Cotrimoxazole Prophylaxis and Longer Breastfeeding Duration to Improve Survival Among HIV-Exposed Infants in Botswana ("Mpepu")
Status:Completed
Find Out More
Acceptability and uptake of HIV self-testing among female sex workers in Botswana: Ikitse Study
Status:Completed
Find Out More
Assessing the potential role of a novel hand-held device (the Intelligent Breast Exam), in breast cancer screening in Botswana: A feasibility pilot study
Status:Completed
Find Out More
Botswana Combination Prevention Project (BCPP) / Ya Tsie Study
Status:Completed
Find Out More
Botswana COVID-19 Active Case Finding Pilot Study and Demonstration Project
Status:Completed
Find Out More
COVID-19: An observational cohort of cases treated in Gaborone, Botswana
Status:Completed
Find Out More
Effects of HIV and ARV Exposure on Child Health and Neurodevelopment, Botswana (“Tshipidi”)
Status:Completed
Find Out More
Effects of preterm birth on HIV acquisition risk and antiretroviral prophylaxis in HIV-exposed infants in Botswana (PERHAPS)
Status:Completed
Find Out More
Innovating to save lives: Evaluation of breast cancer care and outcomes in the setting of Breast multidisciplinary clinic in Botswana (Maduo Study)
Status:Completed
Find Out More
Kgothatso: Male cancer care barriers in Botswana
Pagination
First page
« First
Previous page
‹ Previous
Page
1
Page
2
Page
3
Current page
4
Page
5
Next page
Next ›
Last page
Last »
Media
April 23, 2024
BHP & TESA host Stakeholder Community Engagement on Clinical Trials
April 02, 2024
Prof. Koofhethile Appointed Adjunct Professor at UNIVEN
January 08, 2024
BHP Investigators Elected in ACTG Committees
November 28, 2023
BHP launches Tshireletso Study
View All
Home
About
Who We Are
History
Governance
Board of Members
Board of Directors
Executive Management
Senior Management
Principal Investigators
Our Capacity
Partners
Collaborators
Sponsors
Careers
Tenders
Download Expression of Interest
Policies
Research
Research Themes
Studies
Ongoing Studies
Completed Studies
Laboratory
Pharmacy
Clinical Research Sites
Data Management
Regulatory
Publications
Capacity Building
Training
Projects
Community Engagement
Community Engagement Activities
Community Advisory Boards
Media
News
Newsletters
Press Releases
Annual Reports
Videos
Donate